• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    UL Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    5/6/25 7:01:34 AM ET
    $ULS
    Precision Instruments
    Health Care
    Get the next $ULS alert in real time by email
    uls-20250506
    false000190144000019014402025-05-062025-05-06






    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________________
    FORM 8-K
    ___________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (date of earliest event reported): May 6, 2025
    ___________________________________
    UL Solutions Inc.
    (Exact name of registrant as specified in its charter)
    ___________________________________

    Delaware
    (State or other jurisdiction of
    incorporation or organization)
    001-42012
    (Commission File Number)
    27-0913800
    (I.R.S. Employer Identification Number)
    333 Pfingsten Rd
    Northbrook, Illinois 60062
    (Address of principal executive offices and zip code)
    (847) 272-8800
    (Registrant's telephone number, including area code)
    ___________________________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol
    Name of each exchange on which registered
    Class A Common Stock, par value $0.001 per shareULSNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐








    Item 2.02. Results of Operations and Financial Condition
    On May 6, 2025, UL Solutions Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2025. The full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
    The information contained or incorporated by reference in this Item 2.02, including the press release furnished herewith as Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.
    Item 9.01. Financial Statements and Exhibits
    (d) Exhibits
    Exhibit NumberDescription
    99.1
    Press Release of UL Solutions Inc., dated as of May 6, 2025
    104Cover page interactive data file (embedded with the inline XBRL document)
    Signature
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
    UL Solutions Inc.
    Date: May 6, 2025
    By:/s/ Ryan D. Robinson
    Ryan D. Robinson
    Executive Vice President and Chief Financial Officer


    Get the next $ULS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ULS

    DatePrice TargetRatingAnalyst
    10/7/2024$60.00Buy
    Citigroup
    7/12/2024$41.00 → $46.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ULS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UL Solutions Inc. Reports Strong First Quarter 2025 Results

      First Quarter 2025 (Comparisons to First Quarter 2024 unless otherwise noted)1 Strong revenue growth of 5.2% to $705 million, including 7.6% organic growth Net income of $71 million increased 18.3%, Net income margin of 10.1%, expanded 110 basis points Diluted earnings per share of $0.33 increased 17.9%, Adjusted Diluted Earnings Per Share of $0.37 increased 32.1% Adjusted EBITDA of $161 million increased 22.9%, Adjusted EBITDA margin of 22.8% expanded 320 basis points UL Solutions Inc. (NYSE:ULS), a global safety science leader in independent third-party testing, inspection and certification services and related software and advisory offerings, today reported results for the firs

      5/6/25 7:00:00 AM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Earns Platinum Medal from EcoVadis for Sustainability Performance

      Achieving the top EcoVadis rating reflects the safety science company's commitment to corporate sustainability UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced that it has achieved a Platinum Medal from EcoVadis, a leader in business sustainability assessments, placing it in the top 1% of companies assessed by EcoVadis globally in the past 12 months. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250421295124/en/ UL Solutions improved its rating from Silver – bypassing Gold – to reach EcoVadis' top Platinum rating this year. More than 150,000 companies have been rated by EcoVadis. "We are

      4/22/25 12:25:00 PM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Inc. Sets Date for First Quarter 2025 Results

      UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the first quarter 2025 before the market opens on Tuesday, May 6. Management will host a webcast and conference call that same day at 8:30 a.m. EDT (7:30 a.m. CDT) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions' website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the conference call will be ava

      4/22/25 7:00:00 AM ET
      $ULS
      Precision Instruments
      Health Care

    $ULS
    Leadership Updates

    Live Leadership Updates

    See more
    • UL Solutions Inc. Names New Chief Legal Officer

      UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Scott D'Angelo as executive vice president and chief legal officer, effective April 21, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250311928632/en/UL Solutions names Scott D'Angelo as executive vice president and chief legal officer (Photo: Business Wire) D'Angelo's appointment fills a vacant role and he joins the company's executive leadership team, reporting to President and CEO Jennifer Scanlon. D'Angelo will oversee the legal, brand integrity, ethics and compliance functions. He most recently served as vice presiden

      3/11/25 9:15:00 AM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Names Chief Business Operations and Innovation Officer

      Alex Dadakis to join UL Solutions leadership team in newly created role UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it appointed Alex Dadakis as Executive Vice President, Chief Business Operations and Innovation Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205299962/en/UL Solutions announced the appointment of Alex Dadakis as Executive Vice President, Chief Business Operations and Innovation Officer, effective Jan. 27, 2025. (Photo: Business Wire) Dadakis, who most recently served as Senior Vice President, Global Head of Strategy and Corporate Development at Germany-ba

      12/5/24 4:15:00 PM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Acquires Germany-Based Battery Testing and Simulation Company BatterieIngenieure

      Deal deepens UL Solutions' global expertise in battery performance testing and expands our global EV battery testing footprint. UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced our acquisition of BatterieIngenieure GmbH, a battery testing company based in Aachen, Germany, with expertise in specialized performance testing of cell, small modules and battery systems used in electric vehicles and other applications. The acquisition augments UL Solutions' global battery testing footprint with a laboratory in Europe. BatterieIngenieure provides comprehensive testing, simulation and failure analysis of battery technologies, with distinctive expertise in

      5/22/24 8:30:00 AM ET
      $ULS
      Precision Instruments
      Health Care

    $ULS
    Financials

    Live finance-specific insights

    See more
    • UL Solutions Inc. Reports Strong First Quarter 2025 Results

      First Quarter 2025 (Comparisons to First Quarter 2024 unless otherwise noted)1 Strong revenue growth of 5.2% to $705 million, including 7.6% organic growth Net income of $71 million increased 18.3%, Net income margin of 10.1%, expanded 110 basis points Diluted earnings per share of $0.33 increased 17.9%, Adjusted Diluted Earnings Per Share of $0.37 increased 32.1% Adjusted EBITDA of $161 million increased 22.9%, Adjusted EBITDA margin of 22.8% expanded 320 basis points UL Solutions Inc. (NYSE:ULS), a global safety science leader in independent third-party testing, inspection and certification services and related software and advisory offerings, today reported results for the firs

      5/6/25 7:00:00 AM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Inc. Sets Date for First Quarter 2025 Results

      UL Solutions Inc. (NYSE:ULS), a global leader in applied safety science, today announced it will release financial results for the first quarter 2025 before the market opens on Tuesday, May 6. Management will host a webcast and conference call that same day at 8:30 a.m. EDT (7:30 a.m. CDT) to review results. Webcast and Conference Call The conference call will be broadcast live over the Internet. Additionally, a slide presentation will accompany the conference call. To listen to the call and view the slides, please visit the Investors section of UL Solutions' website at www.ul.com. For those who are unable to listen to the live broadcast, an audio replay of the conference call will be ava

      4/22/25 7:00:00 AM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Announces Increased Quarterly Dividend

      UL Solutions Inc. (NYSE:ULS), a global safety science leader, today announced that its board of directors has declared a quarterly dividend of $0.13 per share, an increase of $0.005 per share, bringing the annual dividend rate to $0.52 per share, up 4% from the previous annual rate. The dividend will be paid on March 10, 2025, to shareholders of record as of the close of business on Feb. 28, 2025. "UL Solutions is pleased to increase our quarterly dividend and provide this additional return to shareholders," said Jennifer Scanlon, president and CEO. About UL Solutions A global leader in applied safety science, UL Solutions Inc. transforms safety, security and sustainability challenges

      2/12/25 7:00:00 AM ET
      $ULS
      Precision Instruments
      Health Care

    $ULS
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by UL Solutions Inc.

      SCHEDULE 13G - UL Solutions Inc. (0001901440) (Subject)

      5/6/25 5:16:10 PM ET
      $ULS
      Precision Instruments
      Health Care
    • SEC Form 10-Q filed by UL Solutions Inc.

      10-Q - UL Solutions Inc. (0001901440) (Filer)

      5/6/25 4:16:26 PM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - UL Solutions Inc. (0001901440) (Filer)

      5/6/25 7:01:34 AM ET
      $ULS
      Precision Instruments
      Health Care

    $ULS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Citigroup resumed coverage on UL Solutions Inc. with a new price target

      Citigroup resumed coverage of UL Solutions Inc. with a rating of Buy and set a new price target of $60.00

      10/7/24 8:45:25 AM ET
      $ULS
      Precision Instruments
      Health Care
    • UL Solutions Inc. downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded UL Solutions Inc. from Outperform to Neutral and set a new price target of $46.00 from $41.00 previously

      7/12/24 7:43:51 AM ET
      $ULS
      Precision Instruments
      Health Care

    $ULS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP & CCO Uggetti Alberto sold $137,270 worth of shares (1,961 units at $70.00), decreasing direct ownership by 17% to 9,285 units (SEC Form 4)

      4 - UL Solutions Inc. (0001901440) (Issuer)

      5/9/25 6:45:06 PM ET
      $ULS
      Precision Instruments
      Health Care
    • Officer Schjotz Gitte sold $472,080 worth of shares (7,000 units at $67.44), decreasing direct ownership by 13% to 46,889 units (SEC Form 4)

      4 - UL Solutions Inc. (0001901440) (Issuer)

      5/9/25 4:30:10 PM ET
      $ULS
      Precision Instruments
      Health Care
    • Director Lambert Lisa Marie converted options into 4,927 shares, increasing direct ownership by 552% to 5,819 units (SEC Form 4)

      4 - UL Solutions Inc. (0001901440) (Issuer)

      5/6/25 6:00:50 PM ET
      $ULS
      Precision Instruments
      Health Care

    $ULS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

      SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

      11/13/24 12:26:41 PM ET
      $ULS
      Precision Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by UL Solutions Inc.

      SC 13G/A - UL Solutions Inc. (0001901440) (Subject)

      11/12/24 5:49:12 PM ET
      $ULS
      Precision Instruments
      Health Care
    • SEC Form SC 13G filed by UL Solutions Inc.

      SC 13G - UL Solutions Inc. (0001901440) (Subject)

      11/12/24 10:34:15 AM ET
      $ULS
      Precision Instruments
      Health Care